Member Info for CityWatcher

Since their consolidation the interim dividend has risen accordingly & might be going ex div in around 9 days time or before. Equates to 25th August as I write this. So a bullish results posting besides their dividend could be why this is rising well.

Guessing that investors are pulling their money out for another investment. Risky with TEK being so low. I can remember taking profits not too long ago at 32.5p. TEK has most likely bottomed out today.

Abingdon Health shares rose after it said its pregnancy test – the first to use a saliva sample rather than urine – will be rolled out by Tesco from the end of this month.

The company, which made Covid kits during the pandemic, distributes the Salistick tests in the UK and Ireland on behalf of the Israeli company Salignostics. Britain’s biggest supermarket will launch the product in 298 stores and online.

Shares surged 28.6 per cent, or 2.5p, to 11.25p after a rocky period since it listed in 2020.

https://www.thisismoney.co.uk/money/markets/article-12409629/MARKET-REPORT-William-Hill-proves-winner-owner-888.html

You could well be right with your forecast as I unfortunately offloaded some ABDX when they rose well in June on their announcement re Superdrug. I did sell out at 12.66p though. It will soon rise above that price ! 40 - 50p very reachable.

Good article & I have a small holding in PYC.

News in today may make ABDX be one of the biggest riser's though.

'' Salistick™, the first ever saliva pregnancy test, to be launched in Tesco

York, U.K. 15 August 2023: Abingdon Health plc (AIM: ABDX), is pleased to announce that Tesco will roll-out Salistick™, the first-ever saliva pregnancy test, in 298 stores and online at Tesco.com from late-August 2023.

The launch of Salistick™ will be focused on larger Tesco stores as well as online at Tesco.com. This follows the initial launch of Salistick™ with Superdrug in 400 stores and online at Superdrug.com.

The Salistick™ pregnancy test offers women an improved user experience, with high accuracy for early pregnancy detection. The revolutionary patented technology allows saliva to be used as a sample rather than the traditional urine sample. Salistick™ offers the ability to test anywhere, anytime, and for the testing experience to be shared with a partner and other loved ones. It is estimated that 12.5 million pregnancy tests were performed in the UK in 2022. The global pregnancy test kits market was valued at USD 1.70 billion in 2022 and is expected to reach USD 2.28 billion by 2028, growing at a CAGR of 5.08%(1). ''

Shares were a bargain price first thing. Can only see more interest in this share now they have obtained some funds. Celebration time for investors if they eventually retrieve the funds also owed.

Wonder why the downgrade after their positive news !

Barclays cuts IWG price target to 135 (150) pence - 'equal weight'

Pelatro confirms that it is experiencing unusual delays in collection of receivables from four specific customers, together amounting to c.$1.1m (of total receivables of $4.2m). The Company is in active and constructive discussions with the four customers and expects a positive resolution.

So the company might update shareholders soon with some positive news. Even if they don't receive the funds by Oct. they are sure to announce another contract win.

Shares in Hochschild Mining soared yesterday as the seller of silver and gold said it had received a long-awaited green light for one of its mines.

Its share price increased by 17.5 per cent, or 13.3p, to 89.5p.

The British-based company, which employs 3,600 people, said its Inmaculada mine in southwest Peru had been granted an environmental permit for another 20 years.

Boss Ignacio Bustamante said the development would add significant value and boost productivity at the site.

Shares in Hochschild Mining soared yesterday as the seller of silver and gold said it had received a long-awaited green light for one of its mines.

Its share price increased by 17.5 per cent, or 13.3p, to 89.5p.

The British-based company, which employs 3,600 people, said its Inmaculada mine in southwest Peru had been granted an environmental permit for another 20 years.

Boss Ignacio Bustamante said the development would add significant value and boost productivity at the site.

HOCHSCHILD'S Q2 Production Report 25th July was impressive too. Given today's news I look forward to a 100% return maybe, having nearly been invested here for a year.

It also confirmed plans to build two more carbon-capture facilities along the North Sea coast, at Acorn in northeast Scotland and Viking near Humber, England - which are operated by Harbour Energy PLC - alongside two already under construction,

It said the four clusters could support up to 50,000 jobs by 2030.

Their 18 year old business newspaper was snapped up yesterday by THG.

https://www.cityam.com/

Shield Therapeutics STX has a positve posting on Proactive Investments.

Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol).

The group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand.

Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co in the Republic of Korea, and with KYE Pharmaceuticals in Canada.

Yea, with the payment of dividend in 9 days time, it's great that British Land is rising 8% today. They should also pay an interim later in year around 10p, probably ex div around 23rd Nov. May fall back owing to the payment 28th July, but hopefully not much, so a sound investment for recovery.

Might be a very good reason to buy if the drop is significant. They do pay a generous dividend normally too.

Zinc Media Group plc (AIM: ZIN), the award-winning television, brand and audio production group, is pleased to announce a trading update ahead of its Capital Market Day ("CMD") being held today.

As at the end of June, total revenue won and due to be recognised in FY23 is now £31m. This figure exceeds the total revenue generated in the whole of FY22, and represents Zinc's best performance at this stage in a financial year for over a decade. All divisions continue to deliver revenue growth despite increasing economic headwinds. The Group's pipeline remains strong with a further £7m of revenue for recognition in FY23 in highly advanced dicsussions.

The Group is delighted that its newest television label Atomic Television has won its first commission. It is a substantial contract worth over £1m for an international bluechip broadcaster. Atomic only launched at the beginning of the year and is a new TV production label based in Bristol specialising in premium specialist factual within the genres of history, science and adventure, focussing on the lucrative US market, alongside the UK.

RBC cuts Dunelm to 'underperform' ('sector perform') - price target 1,000 (1,300) pence

Yes - just noticed he had purchased a round amount of 0.5 m shares quantity. Wealthy guy. Likes a decent return on his investment too you bet !

Was getting ready to maybe buy into housing stocks after the further interest rare rise yesterday. No rush I thought & after today's broker rating by HSBC - no need to have Barratt in my portfolio.

HSBC cuts Barratt Developments to 'hold' - price target 440 pence